Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Counsyl | RCV000411910 | SCV000487743 | pathogenic | Peroxisome biogenesis disorder 1A (Zellweger) | 2016-10-11 | criteria provided, single submitter | clinical testing | |
Counsyl | RCV000409397 | SCV000487744 | pathogenic | Peroxisome biogenesis disorder 1B | 2016-10-11 | criteria provided, single submitter | clinical testing | |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV000780585 | SCV000917981 | likely pathogenic | Peroxisome biogenesis disorder | 2018-05-10 | criteria provided, single submitter | clinical testing | Variant summary: PEX1 c.547C>T (p.Arg183X) results in a premature termination codon, predicted to cause a truncation of the encoded protein or absence of the protein due to nonsense mediated decay, which are commonly known mechanisms for disease. Truncations downstream of this position have been classified as pathogenic by our laboratory (eg. c.2097dupT, p.Ile700fsX42; c.2368C>T, p.Arg790X; c.2916delA, p.Gly973fsX16). The variant allele was found at a frequency of 8.2e-06 in 244450 control chromosomes (gnomAD). This frequency is not significantly higher than expected for a pathogenic variant in PEX1 causing Zellweger Syndrome (8.2e-06 vs 3.90e-03), allowing no conclusion about variant significance. The variant, c.547C>T, has been reported in the literature in individuals affected with Zellweger Syndrome (Ebberink_2010, Yik_2009). To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. One clinical diagnostic laboratory has submitted clinical-significance assessments for this variant to ClinVar after 2014 without evidence for independent evaluation and classified the variant as pathogenic. Based on the evidence outlined above, the variant was classified as likely pathogenic. |
Invitae | RCV001376604 | SCV001220652 | pathogenic | Zellweger spectrum disorders | 2023-10-16 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Arg183*) in the PEX1 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in PEX1 are known to be pathogenic (PMID: 21031596, 26387595, 31831025). This variant is present in population databases (rs149806989, gnomAD 0.01%). This premature translational stop signal has been observed in individuals with Zellweger syndrome (PMID: 19105186). ClinVar contains an entry for this variant (Variation ID: 371782). For these reasons, this variant has been classified as Pathogenic. |
Fulgent Genetics, |
RCV002488843 | SCV002804468 | pathogenic | Peroxisome biogenesis disorder 1A (Zellweger); Heimler syndrome 1; Peroxisome biogenesis disorder 1B | 2021-07-28 | criteria provided, single submitter | clinical testing | |
Baylor Genetics | RCV003475991 | SCV004203346 | pathogenic | Heimler syndrome 1 | 2023-05-20 | criteria provided, single submitter | clinical testing |